Diagnostics firm secures €2m for blood test for pregnant women
Company: Metabolomic Diagnostics
Done Deal:€2 million EU funding
The clincher:“We plan to market the product next year, and with this support from EU, we believe that PrePsia has the potential to become part of pregnancy screening programmes worldwide” - Charles Garvey, chief executive, Metabolomic Diagnostics
Biotech start-up Metabolomic Diagnostics has secured €2 million in EU funding under the Horizon 2020 SME Instrument.
The Cork company is developing a blood test, which can be ...